Buy TEOSYAL® PURESENSE REDENSITY II 2 × 1 ml Online for Professional Use

TEOSYAL® PURESENSE REDENSITY II is a professional hyaluronic acid injectable developed for qualified healthcare professionals working in aesthetic medicine, particularly for protocols involving the tear trough and periorbital area.

Medical professionals and aesthetic clinics can buy TEOSYAL® Redensity II 2 × 1 ml online from Glow Health with professional supply, product traceability and delivery to clinics in Spain and Portugal.

Explore our complete range of TEOSYAL® products or browse our selection of professional dermal fillers.

TEOSYAL® Redensity II Product Information

• Product: TEOSYAL® PURESENSE REDENSITY II
• Manufacturer: Teoxane Laboratories
• Active ingredient: Hyaluronic acid
• Hyaluronic acid concentration: 15 mg/ml
• Lidocaine: 3 mg/ml
• Pack size: 2 prefilled syringes × 1 ml
• Professional use: For qualified healthcare professionals and aesthetic medicine clinics

What is TEOSYAL® PURESENSE REDENSITY II?

TEOSYAL® PURESENSE REDENSITY II is an injectable hyaluronic acid product developed by Teoxane Laboratories for professional aesthetic medicine.

Its formulation is designed for the delicate periorbital and tear trough area, where practitioners require a product specifically developed for precise correction while maintaining a natural appearance.

The formulation also contains lidocaine and a dermo-restructuring complex with selected amino acids, antioxidants, minerals and vitamin B6.

TEOSYAL® Redensity II Composition

The formulation includes:

• Hyaluronic acid: 15 mg/ml
• Lidocaine hydrochloride: 3 mg/ml
• Vitamin B6
• Minerals: copper and zinc
• Amino acids: glycine, lysine, threonine, proline, leucine, arginine, valine and isoleucine
• Antioxidants: alpha-lipoic acid, N-acetyl-L-cysteine and glutathione

Healthcare professionals should always consult the current product information and manufacturer instructions supplied with the product before use.

What is Included in a Box of TEOSYAL® Redensity II?

Each pack contains:

• 2 prefilled syringes × 1 ml
• 4 × 30G 1/2" needles
• Product information supplied with the pack
• Traceability labels for professional record keeping

TEOSYAL® Redensity II for the Periorbital and Tear Trough Area

TEOSYAL® Redensity II is specifically associated with professional aesthetic protocols for the under-eye, tear trough and periorbital area.

Its formulation distinguishes it from products intended primarily for larger-volume facial correction. Product selection and treatment planning should always be based on professional clinical assessment and the manufacturer's current instructions.

For further professional information about this reference, see our guide to TEOSYAL® Redensity II risks, side effects and the Tyndall effect.

TEOSYAL® Redensity II vs Redensity I

TEOSYAL® Redensity II and Redensity I belong to the same professional product family but are designed for different aesthetic applications.

Redensity II is specifically associated with correction of the tear trough and periorbital area, while Redensity I is positioned primarily as a skin quality and revitalisation product.

Practitioners should choose the appropriate reference according to the treatment area, patient assessment and the manufacturer's indications.

Storage of TEOSYAL® Redensity II

Store the product according to the conditions indicated by the manufacturer and the information supplied with the pack.

• Store between 2°C and 25°C.
• Protect from direct sunlight and UV exposure.
• Check the expiry date and packaging integrity before professional use.

TEOSYAL® Redensity II for Aesthetic Medicine Professionals

TEOSYAL® PURESENSE REDENSITY II is intended for use by qualified healthcare professionals familiar with injectable hyaluronic acid products and appropriate aesthetic medicine protocols.

Preparation, product selection and administration should follow the current manufacturer instructions, professional training and applicable clinical requirements.

Professionals researching supply, format and purchasing criteria can also consult our professional guide to buying TEOSYAL® Redensity II for clinics.

Why Buy TEOSYAL® Redensity II from Glow Health?

Glow Health supplies professional aesthetic medicine products to healthcare professionals and clinics in Spain and Portugal.

• Professional B2B supply
• Product traceability
• Current stock information online
• Fast delivery to professional clinics
• Access to a specialised catalogue of injectable aesthetic products

Practitioners comparing products for the tear trough area can also read our professional comparison of TEOSYAL® Redensity II vs Belotero Balance.

Buy TEOSYAL® Redensity II 2 × 1 ml Online

Qualified healthcare professionals and aesthetic medicine clinics can buy TEOSYAL® PURESENSE REDENSITY II 2 × 1 ml online directly from Glow Health.

Check the current TEOSYAL® Redensity II price, stock availability and professional purchasing conditions on this product page before placing your order.

Frequently Asked Questions About TEOSYAL® Redensity II

What is TEOSYAL® Redensity II used for in aesthetic medicine?

TEOSYAL® Redensity II is a professional hyaluronic acid injectable specifically associated with treatment protocols involving the tear trough and periorbital area.

How much hyaluronic acid does TEOSYAL® Redensity II contain?

The formulation contains 15 mg/ml of hyaluronic acid.

Does TEOSYAL® Redensity II contain lidocaine?

Yes. TEOSYAL® PURESENSE REDENSITY II contains 3 mg/ml of lidocaine.

How many syringes are included in the box?

Each pack contains 2 prefilled syringes of 1 ml each.

Who manufactures TEOSYAL® Redensity II?

TEOSYAL® Redensity II is manufactured by Teoxane Laboratories, based in Geneva, Switzerland.

Who can buy TEOSYAL® Redensity II from Glow Health?

Glow Health supplies TEOSYAL® Redensity II and other professional aesthetic medicine products to qualified healthcare professionals and medical clinics.

Where can I find other TEOSYAL® products?

You can browse the complete TEOSYAL® range available at Glow Health to check other professional references and current availability.